The hidden influence of communities in collaborative funding of clinical science.
collaborative funding
population health
science of funding
science of science
science of success
Journal
Royal Society open science
ISSN: 2054-5703
Titre abrégé: R Soc Open Sci
Pays: England
ID NLM: 101647528
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
21
01
2021
accepted:
19
07
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
epublish
Résumé
Every year the National Institutes of Health allocates $10.7 billion (one-third of its funds) for clinical science research while the pharmaceutical companies spend $52.9 billion (90% of its annual budget). However, we know little about funder collaborations and the impact of collaboratively funded projects. As an initial effort towards this, we examine the co-funding network, where a funder represents a node and an edge signifies collaboration. Our core data include all papers that cite and receive citations by the Cochrane Database of Systemic Reviews, a prominent clinical review journal. We find that 65% of clinical papers have multiple funders and discover communities of funders that are formed by national boundaries and funding objectives. To quantify success in funding, we use a
Identifiants
pubmed: 34457332
doi: 10.1098/rsos.210072
pii: rsos210072
pmc: PMC8385381
doi:
Banques de données
figshare
['10.6084/m9.figshare.c.5564401']
Dryad
['10.5061/dryad.2jm63xsnq']
Types de publication
Journal Article
Langues
eng
Pagination
210072Informations de copyright
© 2021 The Authors.
Références
BMJ. 2005 May 7;330(7499):1053
pubmed: 15817526
J Public Econ. 2011 Oct 1;95(9-10):1168-1177
pubmed: 21857758
Science. 2013 Oct 25;342(6157):468-72
pubmed: 24159044
Vaccine. 2021 Apr 22;39(17):2458-2466
pubmed: 33781600
Clin Psychol Sci. 2014 Jan 1;2(1):22-34
pubmed: 25821658
PLoS One. 2021 May 12;16(5):e0251488
pubmed: 33979400
N Engl J Med. 2011 Mar 3;364(9):789-91
pubmed: 21366470
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2329-2334
pubmed: 29440428
Cell Stem Cell. 2018 Jun 1;22(6):801-805
pubmed: 29859170
Res Synth Methods. 2020 Mar;11(2):169-180
pubmed: 31127978
J Evid Based Med. 2014 May 6;:
pubmed: 25156081
JAMA. 2004 Mar 3;291(9):1120-6
pubmed: 14996782
PLoS One. 2015 Feb 19;10(2):e0117727
pubmed: 25695739
BMJ Open. 2018 Mar 25;8(3):e020869
pubmed: 29581210
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33170810
J Health Econ. 2016 May;47:20-33
pubmed: 26928437
Science. 2018 Mar 2;359(6379):
pubmed: 29496846
Science. 2005 Jun 24;308(5730):1867
pubmed: 15976286
Drug Discov Today. 2012 Oct;17(19-20):1088-102
pubmed: 22627006
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
N Engl J Med. 2017 May 4;376(18):1762-1769
pubmed: 28467868
JAMA. 2020 Jun 23;323(24):2455-2457
pubmed: 32421150
BMJ. 2006 May 6;332(7549):1061-4
pubmed: 16547014
Harv Bus Rev. 1999 Mar-Apr;77(2):106-16, 187
pubmed: 10387767
J Gen Intern Med. 2021 Feb;36(2):518-520
pubmed: 33201425
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4887-4890
pubmed: 29686094
Science. 2007 May 18;316(5827):1036-9
pubmed: 17431139
J Clin Invest. 2020 Apr 1;130(4):1545-1548
pubmed: 32167489